Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
6th Annual PREDiCT: 3D Tissue Models Summit

6th Annual PREDiCT: 3D Tissue Models Summit

Categories

Date of beginning

Tuesday, 21 September 2021

Duration

3 days

Deadline for abstracts

Friday, 17 September 2021

City

Boston

Country

United States

Contact

Jessica Durston

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

The 6th PREDiCT: 3D Tissue Models Summit is the only industry-led summit focusing on real-world application of 3D models in drug discovery and development. With 25+ experts sharing fresh case studies on 3D Tissue Models data, how to foster technology maturation, and lower costs to drive industrial adoption, this is a conversation not to miss. Our 2021 program will delve further into advanced 3D organoids, organ-on-chips, microphysiological systems (MPS), and tissue engineering – from oncology to other therapeutic areas such as neurodegenerative, respiratory, fibrosis, and the cardiovascular fields. Explore preclinical safety and toxicology models and translation in clinical Ph1 for biomarkers and patient stratification for better Ph2 design. Join over 120+ senior leaders including Pfizer, Takeda, GSK, Roche, and FDA in September, to re-engage in the dialogue and discuss journeys and lessons learned with complex in vitro models, compared with conventional in vivo and 2D cell studies. Date and Time: On Tuesday September 21, 2021 at 8:00 am (ends Thursday September 23, 2021 at 6:00 pm) Prices: Drug Developers: Conference + Pre-Conference Workshop: USD 3248.00,Drug Developers: Conference Only: USD 2799.00,Academic: Conference + Pre-Conference Workshop: USD 2548.00,Academic: Conference Only: USD 2199.00,Service Providers: Conference + Pre-Conference Workshop: USD 4098.00,Service Providers: Conference Only: USD 3499.00 URLs: Tickets: https://go.evvnt.com/798109-1?pid=5569 Brochure: https://go.evvnt.com/798109-3?pid=5569 Speakers: Madhu Lal-Nag, FDA, Matthew Wagoner, Takeda, Don Ingber, Wyss Institute for Biologically Inspired Engineering, Jason Ekert, Senior Director and Head of Complex In Vitro Models GSK, Jason Ekert, GSK, Roger Kamm, MIT, Danilo Tagle, NIH/ NCATS, Matthew Lech, Pfizer, Nicholas Geisse, Curi Bio, Shamin Li, Roche Diagnostics, Kimberly Homan, Genentech, Phillip Hewitt, Merck KGaA, Stephen Kasper, Merck and Co., Matthias Von Herrath, Novo Nordisk, BanuPriya Sridharan, GSK, Serah Kang, Genentech, Ruitao Su, University of Minnesota, Trivia Frazier, Obatala Sciences, Prathap Kumar, Abbvie, Madhuri Dey, Pennsylvania State University, Jos Joore, MIMETAS, Kristin Fabre, Baylor College, Jeroen Pouwels, University of Helsinki, Timothy Spicer, The Scripps Research Institute, Lisa Wagar, University of California Irvine, Annie Moisan, Wellcome Leap, Suwan N. Jayasinghe, UCL, Thomas Hartung, John Hopkins Bloomberg School of Public Health Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States